Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19

This is a rapid test for the qualitative and differential detection of IgM and IgG antibodies against 2019-nCoV in human whole blood, serum or plasma, capable of providing test results in as little as 10 minutes. It comes in 20 tests per kit.

 

This test is CE-IVD. We have also obtained approval from Singapore Health Science Authority (HSA) for the Provisional IVD use in Singapore. This is similar to US FDA EUA and is a very powerful certification and extremely difficult to obtain.

Benefits

• Differential detection of IgM and IgG antibodies covering different stages of 2019-nCoV infection
• Fast time to result: 10 Minutes
• Product clinical performance:

Sensitivity 90.43% (170/188, 65 IgMpositive, 97 IgG positive,8 positive for both IgM and IgG);

Specificity 100% (182/182) using 188 blood specimens
obtained from patients with clinically confirmed COVID-19 and 182 blood specimens from non-infected (2019-nCoV negative) patients;

Accuracy 95.14%.

Source: Veredus Laboratories

CommaXP™ Virus DNA/RNA Extraction Kit (Spin Column), 50/kit

Using silica membrane adsorption technology and unique buffer system, CommaXP® Virus DNA/RNA Extraction Kit can be used for rapid and easy extraction of virus DNA or RNA from blood, tissue, organs, environmental sample, saliva and nasal sample.

The purified DNA/RNA is free from impurities containing protein or other organic compound and is ready for use in several downstream molecular applications involving PCR, RT-PCR, qPCR, qRT-PCR.

Real-time amplification plot of fluorescence

signal from sample containing 10 viral

RNA copies/μL against cycle number.

CommaXP® Virus DNA/RNA 

Extraction Kit (Red)

Commercially available Q

Virus DNA/RNA Extraction Kit (Green)

Source: Veredus Laboratories

VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0

VereRTCoV is very useful for mass and accurate testing of SARS-CoV-2.

This new version has dual N gene targets which enhances tolerance against gene mutations.

 

It not only has high sensitivity of 2 cp/ RT-PCR rxn but the setup is easy; equal volume of 2 reagents reaction mix.

It is also priced competitively. We provide this kit in an easy to use format. It comes in 200 reactions per kit.

It has obtained Provisional Authorization from Singapore Health Science Authority (HSA).

Expecting to obtain CE-IVD in a month’s time.

Compatibility testing with Applied Biosystem® 7500 real-Time PCR system with reference from US CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel.

Amplification Curve 

•CoV-2 (Blue)

•HIC (Green)

Source: Veredus Laboratories

VerePlex™ Biosystem & VereCov Detection Kit

The VerePLEX™ Biosystem combines molecular biology, microfluidics and microelectronics within a single platform.

 

This is a breakthrough in innovation that integrates two powerful molecular biological technologies: PCR and Microarray.

Together with this Biosystem, VereCoV™, a portable Lab-on-Chip application, is capable of detecting, differentiating and identifying SARS-CoV-2 with the additional capability of detecting a subset of SARS-CoV simultaneously within the same test.

Unique Strategy

In a single test of one sample over 3 gene targets for SARS-CoV-2 and SARS-CoV but with differentiation between both Coronaviruses using  specific probes in a total of 6 detection units

Speed: Viral RNA samples to results in less than 2.5 hours


Specificity: Detection of specific targets for 2019-nCoV and
SARS-CoV without cross-reactivity with other 
coronaviruses such as OC43, 229E, KhU1, NL63


Comprehensive: Qualitatively detect 2019-nCoV with the additional capability of detecting a subset of SARS-CoV
simultaneously within the same test


Mobile: The VerePLEX™ Biosystem is designed to be portable for usage at areas such as checkpoints and borders


Easy to Use: The simple workflow allows for minimally trained or non-scientific personnel to run tests

Rapid Updates Available: 

Probes can be updated quickly to include new mutations of the evolving coronaviruses & ensure the right coverage of detection

Source: Veredus Laboratories

 • 7 different applications available and more in the pipeline:

VereCov ™, VereMTB™, VereFever™, VereFluPlus™, 

VereFoodborne™,,VereBeef™ & VereType-E™ 

One panel to test multiple targets: Rapid and simultaneous detection and identification of biological agents in one test.

• Combines PCR & microarray to deliver more data points per test – cost and time savings

Ultra Fast: Due to miniaturization and integration, detection within 2 hours

• Random access for on-demand testing: Flexibility to run different panels on the system

Updates Available: can be updated quickly to include new strains ensuring the right coverage of detection.

Ability for customization: (for hospitals/airports/ checkpoints etc)

Automated Data Analysis: Software is designed to generate result reports real-time to end users in a user-friendly format.

• Case study of implementing these applications for a country’s Bio-defense

Source: Veredus Laboratories

8 Cross Street

Manulife Tower, #28-65

Singapore 048424

+65 81632902

info@routeoneconsulting.com

  • White LinkedIn Icon
Send Us a Message

© 2023 by Route One Consulting.